Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hederer, R. A.
Right arrow Articles by Alexander, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hederer, R. A.
Right arrow Articles by Alexander, D. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 12, No. 4, 505-516, April 2000
© 2000 Japanese Society for Immunology

The CD45 tyrosine phosphatase regulates Campath-1H (CD52)-induced TCR-dependent signal transduction in human T cells

Rosemarie A. Hederer, Christine Guntermann, Nigel Miller, Peter Nagy1, Janos Szollosi1, Sandor Damjanovich1, Geoffrey Hale2 and Denis R. Alexander

Laboratory of Lymphocyte Signalling and Development, Molecular Immunology Programme, The Babraham Institute, Cambridge CB2 4AT, UK
1 Department of Biophysics and Cell Biology, Debrecen University School of Medicine, H-4012 Debrecen, Hungary
2 Therapeutic Antibody Centre, Old Road, Headington, Oxford OX3 7JT, UK

Correspondence to: D. R. Alexander

Campath-1H, a humanized mAb undergoing clinical trials for treatment of leukemia, transplantation and autoimmune diseases, produces substantial lymphocyte depletion in vivo.The antibody binds to CD52, a highly glycosylated molecule attached to the membrane by a glycosylphosphatidylinositol anchor. Cross-linked Campath-1H is known to activate T cells in vitro. We have investigated the molecular basis for these effects by comparing the protein tyrosine phosphorylation signals induced by Campath-1H and the CD3 mAb OKT3 in primary T cells, and in CD45+TCR+, CD45–TCR+ and CD45+TCR– Jurkat subclones transfected with CD52. Our results show that Campath-1H triggers similar tyrosine phosphorylation events as OKT3 in both primary T cells and in the CD45+TCR+ Jurkat sub-clone, albeit at quantitatively lower levels. However, no phospholipase C{gamma}1 activation nor calcium signals were detected in response to CD52 ligation. The CD52-mediated induction of protein tyrosine phosphorylation was absolutely dependent upon the expression of both the TCR and the CD45 phosphotyrosine phosphatase at the cell surface. Cross-linking of Campath-1H was essential for signal transduction in all cells investigated. Fluorescence resonance energy transfer was used to demonstrate CD52 homo-association at the cell surface in Jurkat T cells in a TCR- and CD45-independent manner, and CD52–TCR association in CD45+TCR+ cells. We propose a model to explain the activating effects of Campath-1H in which CD52 mAb cross-linking causes the trapping of TCR polypeptides within molecular complexes at the cell surface, thereby inducing signals via the TCR by a process which depends on the CD45-mediated regulation of the p56lck and p59fyn tyrosine kinases.

Keywords: Campath-1H, CD45, CD52, transduction

Transmitting editor: P. Beverley


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
B. Bielekova and B. L. Becker
Monoclonal antibodies in MS: Mechanisms of action
Neurology, January 5, 2010; 74(1_Supplement_1): S31 - S40.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
S. Parry, N.-K. Wong, R. L Easton, M. Panico, S. M Haslam, H. R Morris, P. Anderson, K. L Klotz, J. C Herr, A. B Diekman, et al.
The sperm agglutination antigen-1 (SAGA-1) glycoforms of CD52 are O-glycosylated
Glycobiology, October 1, 2007; 17(10): 1120 - 1126.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Ortonne, D. Huet, C. Gaudez, A. Marie-Cardine, V. Schiavon, M. Bagot, P. Musette, and A. Bensussan
Significance of circulating T-cell clones in Sezary syndrome
Blood, May 15, 2006; 107(10): 4030 - 4038.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. S. Lee, K. Hanspers, C. S. Barker, A. P. Korn, and J. M. McCune
Gene expression profiles during human CD4+ T cell differentiation
Int. Immunol., August 1, 2004; 16(8): 1109 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Zhang, M. Zhang, C. K. Goldman, J. V. Ravetch, and T. A. Waldmann
Effective Therapy for a Murine Model of Adult T-Cell Leukemia with the Humanized Anti-CD52 Monoclonal Antibody, Campath-1H
Cancer Res., October 1, 2003; 63(19): 6453 - 6457.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Dornan, Z. Sebestyen, J. Gamble, P. Nagy, A. Bodnar, L. Alldridge, S. Doe, N. Holmes, L. K. Goff, P. Beverley, et al.
Differential Association of CD45 Isoforms with CD4 and CD8 Regulates the Actions of Specific Pools of p56lck Tyrosine Kinase in T Cell Antigen Receptor Signal Transduction
J. Biol. Chem., January 11, 2002; 277(3): 1912 - 1918.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.